HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by GILLESPIE, S. H. Articles by EVERETT, D. Search for Related Content PubMed PubMed Citation Articles by GILLESPIE, S. H. Articles by EVERETT, D. Agricola Articles by GILLESPIE, S. H. Articles by EVERETT, D.

A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model

Royal Free & University College Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF and *GR Micro Ltd, 7–9 William Road, London NW1 3ER

Corresponding author: Professor S.H. Gillespie (e-mail: stepheng{at}rfc.ucl.ac.uk).

Received 13 Oct. 2000; revised version accepted 4 Dec. 2000.

Abstract

New agents are urgently needed to meet the threat of multiple drug-resistant tuberculosis and to manage infection with the naturally resistant non-tuberculosis mycobacteria. Earlier fluoroquinolones have been shown to have promising in-vitro activity, although mouse infection and clinical studies suggested that they lack sufficient bactericidal activity. Methods were evaluated to measure the bactericidal activity of fluoroquinolones and to compare the new agent moxifloxacin with other fluoroquinolones with M. fortuitum as a model system. The optimum bactericidal concentrations (OBC) for the fluoroquinolones were: moxifloxacin, 0.55mumg/L; ciprofloxacin and sparfloxacin, 25mumg/L and ofloxacin, 85mumg/L. The bactericidal indices (BI) for moxifloxacin, ciprofloxacin, sparfloxacin and ofloxacin were 1.8, 0.5, 0.2 and 0.2, respectively. Similar ranking was obtained when the time taken to produce one log₁₀ reduction in viable count was calculated. These data indicate that moxifloxacin was the most bactericidal of the fluoroquinolones tested. Such methods provide a simple in-vitro measure that correlates with in-vivo models.

This article has been cited by other articles:

				J. van den Boogaard, G. S. Kibiki, E. R. Kisanga, M. J. Boeree, and R. E. Aarnoutse New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development Antimicrob. Agents Chemother., March 1, 2009; 53(3): 849 - 862. [Full Text] [PDF]

				S. H. Gillespie, S. Basu, A. L. Dickens, D. M. O'Sullivan, and T. D. McHugh Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates J. Antimicrob. Chemother., August 1, 2005; 56(2): 344 - 348. [Abstract] [Full Text] [PDF]

				S. H. Gillespie, R. D. Gosling, and B. M. Charalambous A Reiterative Method for Calculating the Early Bactericidal Activity of Antituberculosis Drugs Am. J. Respir. Crit. Care Med., July 1, 2002; 166(1): 31 - 35. [Abstract] [Full Text] [PDF]